Therillia Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

Therillia General Information

Description

Developer of novel drug candidates designed to provide proof of concept strategies from pre-clinical to clinical stage. The company's drug candidate identifies potential responder patient populations, rational drug combinations, and the utility of clinical biomarkers, enabling sustainable biopharmaceutical companies to reduce the time and cost of achieving proof of concept data for important new therapeutics.

Contact Information

Website
www.therillia.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1000 De La Gauchetière Street West
  • Suite 2100
  • Montreal, Quebec H3B 4W5
  • Canada
+1 (514) 000-0000
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1000 De La Gauchetière Street West
  • Suite 2100
  • Montreal, Quebec H3B 4W5
  • Canada
+1 (514) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therillia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jul-2022 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Therillia’s complete valuation and funding history, request access »

Therillia Executive Team (6)

Name Title Board Seat
Ramy Hobeika Controller
Michael Dixon Chief Executive Officer, President & Board Member
You’re viewing 2 of 6 executive team members. Get the full list »

Therillia Board Members (4)

Name Representing Role Since
Michael Dixon Self Chief Executive Officer, President & Board Member 000 0000
You’re viewing 1 of 4 board members. Get the full list »

Therillia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Therillia Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tavec Pharmaceuticals 18-Apr-2019 0000000000 Biotechnology
To view Therillia’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Therillia Subsidiaries (1)

Company Name Industry Location Founded
Tavec Pharmaceuticals Biotechnology Montreal, Canada 0000
To view Therillia’s complete subsidiaries history, request access »

Therillia Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Tavec Pharmaceuticals 18-Apr-2019 000000000000 Completed
  • 000000000
To view Therillia’s complete exits history, request access »

Therillia FAQs

  • When was Therillia founded?

    Therillia was founded in 2013.

  • Who is the CEO of Therillia?

    Michael Dixon is the CEO of Therillia.

  • Where is Therillia headquartered?

    Therillia is headquartered in Montreal, Canada.

  • What is the size of Therillia?

    Therillia has 5 total employees.

  • What industry is Therillia in?

    Therillia’s primary industry is Drug Discovery.

  • Is Therillia a private or public company?

    Therillia is a Private company.

  • What is Therillia’s current revenue?

    The current revenue for Therillia is 00000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »